Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cefepime Market Growth 2022-2028

  • LP 4832693
  • 125 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cefepime will have significant change from previous year. According to our (LP Information) latest study, the global Cefepime market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cefepime market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cefepime market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cefepime market, reaching US$ million by the year 2028. As for the Europe Cefepime landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cefepime players cover Baxter, Apotex, B. Braun Medical, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cefepime market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Intramuscular Injection

Intravenous Drug Delivery

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Lower Respiratory Tract Infection

Urinary Tract Infection

Skin And Soft Tissue Infections

Abdominal Cavity Infection

Gynecologic Infection

Sepsis

Neutrophilic Fever

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Baxter

Apotex

B. Braun Medical

Pfizer

Perrigo

Fresenius Kabi

Sandoz (Novartis)

Piramal Critical Care

Meitheal Pharmaceuticals

BMS

Qilu Pharmaceutical

Sinopharm

Shanghai Xinfeng Pharmaceutical

Hebei Huamin Pharmaceutical

Nanjing Haichen Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Guangzhou Baiyunshan Tianxin Pharmaceutical

Yuekang Pharmaceutical Group

Chengdu Beite Pharmaceutical

Jiangsu Hengrui Pharmaceutical

Hainan Star Pharmaceutical

Hainan Hailing Pharmaceutical

Shenzhen Xinlitai Pharmaceutical

Shenzhen Lijian Pharmaceutical

Suzhou Dongrui Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cefepime Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cefepime by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cefepime by Country/Region, 2017, 2022 & 2028

2.2 Cefepime Segment by Type

2.2.1 Intramuscular Injection

2.2.2 Intravenous Drug Delivery

2.3 Cefepime Sales by Type

2.3.1 Global Cefepime Sales Market Share by Type (2017-2022)

2.3.2 Global Cefepime Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cefepime Sale Price by Type (2017-2022)

2.4 Cefepime Segment by Application

2.4.1 Lower Respiratory Tract Infection

2.4.2 Urinary Tract Infection

2.4.3 Skin And Soft Tissue Infections

2.4.4 Abdominal Cavity Infection

2.4.5 Gynecologic Infection

2.4.6 Sepsis

2.4.7 Neutrophilic Fever

2.5 Cefepime Sales by Application

2.5.1 Global Cefepime Sale Market Share by Application (2017-2022)

2.5.2 Global Cefepime Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cefepime Sale Price by Application (2017-2022)

3 Global Cefepime by Company

3.1 Global Cefepime Breakdown Data by Company

3.1.1 Global Cefepime Annual Sales by Company (2020-2022)

3.1.2 Global Cefepime Sales Market Share by Company (2020-2022)

3.2 Global Cefepime Annual Revenue by Company (2020-2022)

3.2.1 Global Cefepime Revenue by Company (2020-2022)

3.2.2 Global Cefepime Revenue Market Share by Company (2020-2022)

3.3 Global Cefepime Sale Price by Company

3.4 Key Manufacturers Cefepime Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cefepime Product Location Distribution

3.4.2 Players Cefepime Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cefepime by Geographic Region

4.1 World Historic Cefepime Market Size by Geographic Region (2017-2022)

4.1.1 Global Cefepime Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cefepime Annual Revenue by Geographic Region

4.2 World Historic Cefepime Market Size by Country/Region (2017-2022)

4.2.1 Global Cefepime Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cefepime Annual Revenue by Country/Region

4.3 Americas Cefepime Sales Growth

4.4 APAC Cefepime Sales Growth

4.5 Europe Cefepime Sales Growth

4.6 Middle East & Africa Cefepime Sales Growth

5 Americas

5.1 Americas Cefepime Sales by Country

5.1.1 Americas Cefepime Sales by Country (2017-2022)

5.1.2 Americas Cefepime Revenue by Country (2017-2022)

5.2 Americas Cefepime Sales by Type

5.3 Americas Cefepime Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cefepime Sales by Region

6.1.1 APAC Cefepime Sales by Region (2017-2022)

6.1.2 APAC Cefepime Revenue by Region (2017-2022)

6.2 APAC Cefepime Sales by Type

6.3 APAC Cefepime Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cefepime by Country

7.1.1 Europe Cefepime Sales by Country (2017-2022)

7.1.2 Europe Cefepime Revenue by Country (2017-2022)

7.2 Europe Cefepime Sales by Type

7.3 Europe Cefepime Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cefepime by Country

8.1.1 Middle East & Africa Cefepime Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cefepime Revenue by Country (2017-2022)

8.2 Middle East & Africa Cefepime Sales by Type

8.3 Middle East & Africa Cefepime Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cefepime

10.3 Manufacturing Process Analysis of Cefepime

10.4 Industry Chain Structure of Cefepime

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cefepime Distributors

11.3 Cefepime Customer

12 World Forecast Review for Cefepime by Geographic Region

12.1 Global Cefepime Market Size Forecast by Region

12.1.1 Global Cefepime Forecast by Region (2023-2028)

12.1.2 Global Cefepime Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cefepime Forecast by Type

12.7 Global Cefepime Forecast by Application

13 Key Players Analysis

13.1 Baxter

13.1.1 Baxter Company Information

13.1.2 Baxter Cefepime Product Offered

13.1.3 Baxter Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Baxter Main Business Overview

13.1.5 Baxter Latest Developments

13.2 Apotex

13.2.1 Apotex Company Information

13.2.2 Apotex Cefepime Product Offered

13.2.3 Apotex Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Apotex Main Business Overview

13.2.5 Apotex Latest Developments

13.3 B. Braun Medical

13.3.1 B. Braun Medical Company Information

13.3.2 B. Braun Medical Cefepime Product Offered

13.3.3 B. Braun Medical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 B. Braun Medical Main Business Overview

13.3.5 B. Braun Medical Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Cefepime Product Offered

13.4.3 Pfizer Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Perrigo

13.5.1 Perrigo Company Information

13.5.2 Perrigo Cefepime Product Offered

13.5.3 Perrigo Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Perrigo Main Business Overview

13.5.5 Perrigo Latest Developments

13.6 Fresenius Kabi

13.6.1 Fresenius Kabi Company Information

13.6.2 Fresenius Kabi Cefepime Product Offered

13.6.3 Fresenius Kabi Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fresenius Kabi Main Business Overview

13.6.5 Fresenius Kabi Latest Developments

13.7 Sandoz (Novartis)

13.7.1 Sandoz (Novartis) Company Information

13.7.2 Sandoz (Novartis) Cefepime Product Offered

13.7.3 Sandoz (Novartis) Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sandoz (Novartis) Main Business Overview

13.7.5 Sandoz (Novartis) Latest Developments

13.8 Piramal Critical Care

13.8.1 Piramal Critical Care Company Information

13.8.2 Piramal Critical Care Cefepime Product Offered

13.8.3 Piramal Critical Care Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Piramal Critical Care Main Business Overview

13.8.5 Piramal Critical Care Latest Developments

13.9 Meitheal Pharmaceuticals

13.9.1 Meitheal Pharmaceuticals Company Information

13.9.2 Meitheal Pharmaceuticals Cefepime Product Offered

13.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Meitheal Pharmaceuticals Main Business Overview

13.9.5 Meitheal Pharmaceuticals Latest Developments

13.10 BMS

13.10.1 BMS Company Information

13.10.2 BMS Cefepime Product Offered

13.10.3 BMS Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 BMS Main Business Overview

13.10.5 BMS Latest Developments

13.11 Qilu Pharmaceutical

13.11.1 Qilu Pharmaceutical Company Information

13.11.2 Qilu Pharmaceutical Cefepime Product Offered

13.11.3 Qilu Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Qilu Pharmaceutical Main Business Overview

13.11.5 Qilu Pharmaceutical Latest Developments

13.12 Sinopharm

13.12.1 Sinopharm Company Information

13.12.2 Sinopharm Cefepime Product Offered

13.12.3 Sinopharm Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sinopharm Main Business Overview

13.12.5 Sinopharm Latest Developments

13.13 Shanghai Xinfeng Pharmaceutical

13.13.1 Shanghai Xinfeng Pharmaceutical Company Information

13.13.2 Shanghai Xinfeng Pharmaceutical Cefepime Product Offered

13.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shanghai Xinfeng Pharmaceutical Main Business Overview

13.13.5 Shanghai Xinfeng Pharmaceutical Latest Developments

13.14 Hebei Huamin Pharmaceutical

13.14.1 Hebei Huamin Pharmaceutical Company Information

13.14.2 Hebei Huamin Pharmaceutical Cefepime Product Offered

13.14.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Hebei Huamin Pharmaceutical Main Business Overview

13.14.5 Hebei Huamin Pharmaceutical Latest Developments

13.15 Nanjing Haichen Pharmaceutical

13.15.1 Nanjing Haichen Pharmaceutical Company Information

13.15.2 Nanjing Haichen Pharmaceutical Cefepime Product Offered

13.15.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Nanjing Haichen Pharmaceutical Main Business Overview

13.15.5 Nanjing Haichen Pharmaceutical Latest Developments

13.16 Shandong Luoxin Pharmaceutical Group

13.16.1 Shandong Luoxin Pharmaceutical Group Company Information

13.16.2 Shandong Luoxin Pharmaceutical Group Cefepime Product Offered

13.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Shandong Luoxin Pharmaceutical Group Main Business Overview

13.16.5 Shandong Luoxin Pharmaceutical Group Latest Developments

13.17 Guangzhou Baiyunshan Tianxin Pharmaceutical

13.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information

13.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product Offered

13.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Overview

13.17.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments

13.18 Yuekang Pharmaceutical Group

13.18.1 Yuekang Pharmaceutical Group Company Information

13.18.2 Yuekang Pharmaceutical Group Cefepime Product Offered

13.18.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Yuekang Pharmaceutical Group Main Business Overview

13.18.5 Yuekang Pharmaceutical Group Latest Developments

13.19 Chengdu Beite Pharmaceutical

13.19.1 Chengdu Beite Pharmaceutical Company Information

13.19.2 Chengdu Beite Pharmaceutical Cefepime Product Offered

13.19.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Chengdu Beite Pharmaceutical Main Business Overview

13.19.5 Chengdu Beite Pharmaceutical Latest Developments

13.20 Jiangsu Hengrui Pharmaceutical

13.20.1 Jiangsu Hengrui Pharmaceutical Company Information

13.20.2 Jiangsu Hengrui Pharmaceutical Cefepime Product Offered

13.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Jiangsu Hengrui Pharmaceutical Main Business Overview

13.20.5 Jiangsu Hengrui Pharmaceutical Latest Developments

13.21 Hainan Star Pharmaceutical

13.21.1 Hainan Star Pharmaceutical Company Information

13.21.2 Hainan Star Pharmaceutical Cefepime Product Offered

13.21.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Hainan Star Pharmaceutical Main Business Overview

13.21.5 Hainan Star Pharmaceutical Latest Developments

13.22 Hainan Hailing Pharmaceutical

13.22.1 Hainan Hailing Pharmaceutical Company Information

13.22.2 Hainan Hailing Pharmaceutical Cefepime Product Offered

13.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Hainan Hailing Pharmaceutical Main Business Overview

13.22.5 Hainan Hailing Pharmaceutical Latest Developments

13.23 Shenzhen Xinlitai Pharmaceutical

13.23.1 Shenzhen Xinlitai Pharmaceutical Company Information

13.23.2 Shenzhen Xinlitai Pharmaceutical Cefepime Product Offered

13.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Shenzhen Xinlitai Pharmaceutical Main Business Overview

13.23.5 Shenzhen Xinlitai Pharmaceutical Latest Developments

13.24 Shenzhen Lijian Pharmaceutical

13.24.1 Shenzhen Lijian Pharmaceutical Company Information

13.24.2 Shenzhen Lijian Pharmaceutical Cefepime Product Offered

13.24.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Shenzhen Lijian Pharmaceutical Main Business Overview

13.24.5 Shenzhen Lijian Pharmaceutical Latest Developments

13.25 Suzhou Dongrui Pharmaceutical

13.25.1 Suzhou Dongrui Pharmaceutical Company Information

13.25.2 Suzhou Dongrui Pharmaceutical Cefepime Product Offered

13.25.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Suzhou Dongrui Pharmaceutical Main Business Overview

13.25.5 Suzhou Dongrui Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Cefepime Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cefepime Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Intramuscular Injection

Table 4. Major Players of Intravenous Drug Delivery

Table 5. Global Cefepime Sales by Type (2017-2022) & (K Units)

Table 6. Global Cefepime Sales Market Share by Type (2017-2022)

Table 7. Global Cefepime Revenue by Type (2017-2022) & ($ million)

Table 8. Global Cefepime Revenue Market Share by Type (2017-2022)

Table 9. Global Cefepime Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Cefepime Sales by Application (2017-2022) & (K Units)

Table 11. Global Cefepime Sales Market Share by Application (2017-2022)

Table 12. Global Cefepime Revenue by Application (2017-2022)

Table 13. Global Cefepime Revenue Market Share by Application (2017-2022)

Table 14. Global Cefepime Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Cefepime Sales by Company (2020-2022) & (K Units)

Table 16. Global Cefepime Sales Market Share by Company (2020-2022)

Table 17. Global Cefepime Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Cefepime Revenue Market Share by Company (2020-2022)

Table 19. Global Cefepime Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Cefepime Producing Area Distribution and Sales Area

Table 21. Players Cefepime Products Offered

Table 22. Cefepime Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Cefepime Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Cefepime Sales Market Share Geographic Region (2017-2022)

Table 27. Global Cefepime Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Cefepime Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Cefepime Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Cefepime Sales Market Share by Country/Region (2017-2022)

Table 31. Global Cefepime Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Cefepime Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Cefepime Sales by Country (2017-2022) & (K Units)

Table 34. Americas Cefepime Sales Market Share by Country (2017-2022)

Table 35. Americas Cefepime Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Cefepime Revenue Market Share by Country (2017-2022)

Table 37. Americas Cefepime Sales by Type (2017-2022) & (K Units)

Table 38. Americas Cefepime Sales Market Share by Type (2017-2022)

Table 39. Americas Cefepime Sales by Application (2017-2022) & (K Units)

Table 40. Americas Cefepime Sales Market Share by Application (2017-2022)

Table 41. APAC Cefepime Sales by Region (2017-2022) & (K Units)

Table 42. APAC Cefepime Sales Market Share by Region (2017-2022)

Table 43. APAC Cefepime Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Cefepime Revenue Market Share by Region (2017-2022)

Table 45. APAC Cefepime Sales by Type (2017-2022) & (K Units)

Table 46. APAC Cefepime Sales Market Share by Type (2017-2022)

Table 47. APAC Cefepime Sales by Application (2017-2022) & (K Units)

Table 48. APAC Cefepime Sales Market Share by Application (2017-2022)

Table 49. Europe Cefepime Sales by Country (2017-2022) & (K Units)

Table 50. Europe Cefepime Sales Market Share by Country (2017-2022)

Table 51. Europe Cefepime Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Cefepime Revenue Market Share by Country (2017-2022)

Table 53. Europe Cefepime Sales by Type (2017-2022) & (K Units)

Table 54. Europe Cefepime Sales Market Share by Type (2017-2022)

Table 55. Europe Cefepime Sales by Application (2017-2022) & (K Units)

Table 56. Europe Cefepime Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Cefepime Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Cefepime Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Cefepime Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Cefepime Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Cefepime Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Cefepime Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Cefepime Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Cefepime Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Cefepime

Table 66. Key Market Challenges & Risks of Cefepime

Table 67. Key Industry Trends of Cefepime

Table 68. Cefepime Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Cefepime Distributors List

Table 71. Cefepime Customer List

Table 72. Global Cefepime Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Cefepime Sales Market Forecast by Region

Table 74. Global Cefepime Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Cefepime Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Cefepime Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Cefepime Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Cefepime Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Cefepime Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Cefepime Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Cefepime Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Cefepime Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Cefepime Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Cefepime Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Cefepime Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Cefepime Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Cefepime Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Cefepime Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Cefepime Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Cefepime Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Cefepime Revenue Market Share Forecast by Application (2023-2028)

Table 92. Baxter Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 93. Baxter Cefepime Product Offered

Table 94. Baxter Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Baxter Main Business

Table 96. Baxter Latest Developments

Table 97. Apotex Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 98. Apotex Cefepime Product Offered

Table 99. Apotex Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Apotex Main Business

Table 101. Apotex Latest Developments

Table 102. B. Braun Medical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 103. B. Braun Medical Cefepime Product Offered

Table 104. B. Braun Medical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. B. Braun Medical Main Business

Table 106. B. Braun Medical Latest Developments

Table 107. Pfizer Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 108. Pfizer Cefepime Product Offered

Table 109. Pfizer Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Pfizer Main Business

Table 111. Pfizer Latest Developments

Table 112. Perrigo Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 113. Perrigo Cefepime Product Offered

Table 114. Perrigo Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Perrigo Main Business

Table 116. Perrigo Latest Developments

Table 117. Fresenius Kabi Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 118. Fresenius Kabi Cefepime Product Offered

Table 119. Fresenius Kabi Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Fresenius Kabi Main Business

Table 121. Fresenius Kabi Latest Developments

Table 122. Sandoz (Novartis) Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 123. Sandoz (Novartis) Cefepime Product Offered

Table 124. Sandoz (Novartis) Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Sandoz (Novartis) Main Business

Table 126. Sandoz (Novartis) Latest Developments

Table 127. Piramal Critical Care Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 128. Piramal Critical Care Cefepime Product Offered

Table 129. Piramal Critical Care Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Piramal Critical Care Main Business

Table 131. Piramal Critical Care Latest Developments

Table 132. Meitheal Pharmaceuticals Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 133. Meitheal Pharmaceuticals Cefepime Product Offered

Table 134. Meitheal Pharmaceuticals Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Meitheal Pharmaceuticals Main Business

Table 136. Meitheal Pharmaceuticals Latest Developments

Table 137. BMS Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 138. BMS Cefepime Product Offered

Table 139. BMS Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. BMS Main Business

Table 141. BMS Latest Developments

Table 142. Qilu Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 143. Qilu Pharmaceutical Cefepime Product Offered

Table 144. Qilu Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Qilu Pharmaceutical Main Business

Table 146. Qilu Pharmaceutical Latest Developments

Table 147. Sinopharm Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 148. Sinopharm Cefepime Product Offered

Table 149. Sinopharm Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Sinopharm Main Business

Table 151. Sinopharm Latest Developments

Table 152. Shanghai Xinfeng Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 153. Shanghai Xinfeng Pharmaceutical Cefepime Product Offered

Table 154. Shanghai Xinfeng Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Shanghai Xinfeng Pharmaceutical Main Business

Table 156. Shanghai Xinfeng Pharmaceutical Latest Developments

Table 157. Hebei Huamin Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 158. Hebei Huamin Pharmaceutical Cefepime Product Offered

Table 159. Hebei Huamin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Hebei Huamin Pharmaceutical Main Business

Table 161. Hebei Huamin Pharmaceutical Latest Developments

Table 162. Nanjing Haichen Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 163. Nanjing Haichen Pharmaceutical Cefepime Product Offered

Table 164. Nanjing Haichen Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Nanjing Haichen Pharmaceutical Main Business

Table 166. Nanjing Haichen Pharmaceutical Latest Developments

Table 167. Shandong Luoxin Pharmaceutical Group Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 168. Shandong Luoxin Pharmaceutical Group Cefepime Product Offered

Table 169. Shandong Luoxin Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. Shandong Luoxin Pharmaceutical Group Main Business

Table 171. Shandong Luoxin Pharmaceutical Group Latest Developments

Table 172. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 173. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product Offered

Table 174. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business

Table 176. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments

Table 177. Yuekang Pharmaceutical Group Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 178. Yuekang Pharmaceutical Group Cefepime Product Offered

Table 179. Yuekang Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Yuekang Pharmaceutical Group Main Business

Table 181. Yuekang Pharmaceutical Group Latest Developments

Table 182. Chengdu Beite Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 183. Chengdu Beite Pharmaceutical Cefepime Product Offered

Table 184. Chengdu Beite Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Chengdu Beite Pharmaceutical Main Business

Table 186. Chengdu Beite Pharmaceutical Latest Developments

Table 187. Jiangsu Hengrui Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 188. Jiangsu Hengrui Pharmaceutical Cefepime Product Offered

Table 189. Jiangsu Hengrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 190. Jiangsu Hengrui Pharmaceutical Main Business

Table 191. Jiangsu Hengrui Pharmaceutical Latest Developments

Table 192. Hainan Star Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 193. Hainan Star Pharmaceutical Cefepime Product Offered

Table 194. Hainan Star Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 195. Hainan Star Pharmaceutical Main Business

Table 196. Hainan Star Pharmaceutical Latest Developments

Table 197. Hainan Hailing Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 198. Hainan Hailing Pharmaceutical Cefepime Product Offered

Table 199. Hainan Hailing Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 200. Hainan Hailing Pharmaceutical Main Business

Table 201. Hainan Hailing Pharmaceutical Latest Developments

Table 202. Shenzhen Xinlitai Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 203. Shenzhen Xinlitai Pharmaceutical Cefepime Product Offered

Table 204. Shenzhen Xinlitai Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 205. Shenzhen Xinlitai Pharmaceutical Main Business

Table 206. Shenzhen Xinlitai Pharmaceutical Latest Developments

Table 207. Shenzhen Lijian Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 208. Shenzhen Lijian Pharmaceutical Cefepime Product Offered

Table 209. Shenzhen Lijian Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 210. Shenzhen Lijian Pharmaceutical Main Business

Table 211. Shenzhen Lijian Pharmaceutical Latest Developments

Table 212. Suzhou Dongrui Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors

Table 213. Suzhou Dongrui Pharmaceutical Cefepime Product Offered

Table 214. Suzhou Dongrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 215. Suzhou Dongrui Pharmaceutical Main Business

Table 216. Suzhou Dongrui Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Cefepime

Figure 2. Cefepime Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cefepime Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Cefepime Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cefepime Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Intramuscular Injection

Figure 10. Product Picture of Intravenous Drug Delivery

Figure 11. Global Cefepime Sales Market Share by Type in 2021

Figure 12. Global Cefepime Revenue Market Share by Type (2017-2022)

Figure 13. Cefepime Consumed in Lower Respiratory Tract Infection

Figure 14. Global Cefepime Market: Lower Respiratory Tract Infection (2017-2022) & (K Units)

Figure 15. Cefepime Consumed in Urinary Tract Infection

Figure 16. Global Cefepime Market: Urinary Tract Infection (2017-2022) & (K Units)

Figure 17. Cefepime Consumed in Skin And Soft Tissue Infections

Figure 18. Global Cefepime Market: Skin And Soft Tissue Infections (2017-2022) & (K Units)

Figure 19. Cefepime Consumed in Abdominal Cavity Infection

Figure 20. Global Cefepime Market: Abdominal Cavity Infection (2017-2022) & (K Units)

Figure 21. Cefepime Consumed in Gynecologic Infection

Figure 22. Global Cefepime Market: Gynecologic Infection (2017-2022) & (K Units)

Figure 23. Cefepime Consumed in Sepsis

Figure 24. Global Cefepime Market: Sepsis (2017-2022) & (K Units)

Figure 25. Cefepime Consumed in Neutrophilic Fever

Figure 26. Global Cefepime Market: Neutrophilic Fever (2017-2022) & (K Units)

Figure 27. Global Cefepime Sales Market Share by Application (2017-2022)

Figure 28. Global Cefepime Revenue Market Share by Application in 2021

Figure 29. Cefepime Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Cefepime Revenue Market Share by Company in 2021

Figure 31. Global Cefepime Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Cefepime Revenue Market Share by Geographic Region in 2021

Figure 33. Global Cefepime Sales Market Share by Region (2017-2022)

Figure 34. Global Cefepime Revenue Market Share by Country/Region in 2021

Figure 35. Americas Cefepime Sales 2017-2022 (K Units)

Figure 36. Americas Cefepime Revenue 2017-2022 ($ Millions)

Figure 37. APAC Cefepime Sales 2017-2022 (K Units)

Figure 38. APAC Cefepime Revenue 2017-2022 ($ Millions)

Figure 39. Europe Cefepime Sales 2017-2022 (K Units)

Figure 40. Europe Cefepime Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Cefepime Sales 2017-2022 (K Units)

Figure 42. Middle East & Africa Cefepime Revenue 2017-2022 ($ Millions)

Figure 43. Americas Cefepime Sales Market Share by Country in 2021

Figure 44. Americas Cefepime Revenue Market Share by Country in 2021

Figure 45. United States Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Cefepime Sales Market Share by Region in 2021

Figure 50. APAC Cefepime Revenue Market Share by Regions in 2021

Figure 51. China Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Cefepime Sales Market Share by Country in 2021

Figure 58. Europe Cefepime Revenue Market Share by Country in 2021

Figure 59. Germany Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Cefepime Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Cefepime Revenue Market Share by Country in 2021

Figure 66. Egypt Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Cefepime Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Cefepime in 2021

Figure 72. Manufacturing Process Analysis of Cefepime

Figure 73. Industry Chain Structure of Cefepime

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390